Company Description
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products.
In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates.
Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services.
The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant.
Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,130 |
| CEO | Miguel Martin |
Contact Details
Address: 2207 90b Street Sw Edmonton, A0 T6X 1V8 Alberta, Canada | |
| Phone | 604-362-5207 |
| Website | auroramj.com |
Stock Details
| Ticker Symbol | ACB |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001683541 |
| CUSIP Number | 05156X884 |
| ISIN Number | CA05156X8504 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Miguel Martin | Chief Executive Officer and Director |
| Alex Miller | Executive Vice President of Operations and Supply Chain |
| Lori Schick | Executive Vice President of Human Resources |
| Andre Jerome | Executive Vice President of Global Business Development |
| Simona King | Chief Financial Officer |
| Ananth Krishnan | Vice President of Capital Markets and Investor Relations |
| Nathalie Clark | Executive Vice President, General Counsel and Corporate Secretary |
| Michelle Lefler | Vice President of Communications and Public Relations |
| Dr. Jonathan Page Ph.D. | Senior Science Advisor |
| Rick Savone | Senior Vice President of Global Government Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 1, 2024 | 6-K | Report of foreign issuer |
| Feb 20, 2024 | 6-K | Report of foreign issuer |
| Feb 16, 2024 | 6-K | Report of foreign issuer |
| Feb 8, 2024 | 6-K | Report of foreign issuer |
| Feb 8, 2024 | 6-K | Report of foreign issuer |
| Feb 8, 2024 | 6-K | Report of foreign issuer |
| Jan 31, 2024 | 6-K | Report of foreign issuer |
| Nov 9, 2023 | 6-K | Report of foreign issuer |
| Nov 9, 2023 | 6-K | Report of foreign issuer |
| Oct 27, 2023 | 6-K | Report of foreign issuer |